Trial Outcomes & Findings for Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures (NCT NCT00635479)
NCT ID: NCT00635479
Last Updated: 2017-12-11
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
115 participants
Primary outcome timeframe
Until wound healed, up to 1 year
Results posted on
2017-12-11
Participant Flow
Participant milestones
| Measure |
VAC Device
Vacuum Assisted Closure (VAC) device
Wound Vac: Vacuum Assisted Closure (VAC) device for surgical incision
|
Gauze Dressing
Gauze Dressing
Gauze dressing: Gauze dressing for surgical incision
|
|---|---|---|
|
Overall Study
STARTED
|
55
|
60
|
|
Overall Study
COMPLETED
|
49
|
42
|
|
Overall Study
NOT COMPLETED
|
6
|
18
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures
Baseline characteristics by cohort
| Measure |
VAC Device
n=55 Participants
Vacuum Assisted Closure (VAC) device
Wound Vac: Vacuum Assisted Closure (VAC) device for surgical incision
|
Gauze Dressing
n=60 Participants
Gauze Dressing
Gauze dressing: Gauze dressing for surgical incision
|
Total
n=115 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
47.2 years
STANDARD_DEVIATION 19.6 • n=93 Participants
|
48.3 years
STANDARD_DEVIATION 20.1 • n=4 Participants
|
47.6 years
STANDARD_DEVIATION 19.9 • n=27 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=93 Participants
|
19 Participants
n=4 Participants
|
31 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
43 Participants
n=93 Participants
|
41 Participants
n=4 Participants
|
84 Participants
n=27 Participants
|
|
Region of Enrollment
United States
|
55 participants
n=93 Participants
|
60 participants
n=4 Participants
|
115 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: Until wound healed, up to 1 yearOutcome measures
| Measure |
VAC Device
n=49 Participants
Vacuum Assisted Closure (VAC) device
Wound Vac: Vacuum Assisted Closure (VAC) device for surgical incision
|
Gauze Dressing
n=42 Participants
Gauze Dressing
Gauze dressing: Gauze dressing for surgical incision
|
|---|---|---|
|
Number of Participants With Wound Infections
|
5 participants
|
2 participants
|
Adverse Events
VAC Device
Serious events: 15 serious events
Other events: 3 other events
Deaths: 0 deaths
Gauze Dressing
Serious events: 9 serious events
Other events: 5 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
VAC Device
n=49 participants at risk
Vacuum Assisted Closure (VAC) device
Wound Vac: Vacuum Assisted Closure (VAC) device for surgical incision
|
Gauze Dressing
n=42 participants at risk
Gauze Dressing
Gauze dressing: Gauze dressing for surgical incision
|
|---|---|---|
|
Infections and infestations
infection
|
20.4%
10/49
|
9.5%
4/42
|
|
Gastrointestinal disorders
Perforated colon
|
2.0%
1/49
|
0.00%
0/42
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonia
|
2.0%
1/49
|
2.4%
1/42
|
|
Vascular disorders
CVA
|
0.00%
0/49
|
2.4%
1/42
|
|
Surgical and medical procedures
implant failure
|
4.1%
2/49
|
2.4%
1/42
|
|
General disorders
prescription overdose
|
2.0%
1/49
|
0.00%
0/42
|
|
Vascular disorders
DVT
|
0.00%
0/49
|
2.4%
1/42
|
|
Vascular disorders
PE
|
0.00%
0/49
|
2.4%
1/42
|
Other adverse events
| Measure |
VAC Device
n=49 participants at risk
Vacuum Assisted Closure (VAC) device
Wound Vac: Vacuum Assisted Closure (VAC) device for surgical incision
|
Gauze Dressing
n=42 participants at risk
Gauze Dressing
Gauze dressing: Gauze dressing for surgical incision
|
|---|---|---|
|
Renal and urinary disorders
urinary tract infection
|
0.00%
0/49
|
4.8%
2/42
|
|
Gastrointestinal disorders
ileus
|
2.0%
1/49
|
0.00%
0/42
|
|
Nervous system disorders
Regional Pain Syndrome
|
0.00%
0/49
|
2.4%
1/42
|
|
Respiratory, thoracic and mediastinal disorders
pneumomediastinum
|
2.0%
1/49
|
0.00%
0/42
|
|
Vascular disorders
hematoma
|
2.0%
1/49
|
0.00%
0/42
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
malignancy, unrelated
|
0.00%
0/49
|
2.4%
1/42
|
|
General disorders
fall, no injury
|
0.00%
0/49
|
2.4%
1/42
|
Additional Information
Brett Crist, MD
University of Missouri, Department of Orthopaedics
Phone: 573-882-6562
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place